Link	Year	acute/sustained	gnotobiotic	animal strain	animal sex	animal age value (days)	animal weight value (g)	species	mechanism_of_action	disease model	success measure	tested dose dependently	prophylactic / therapeutic	ribotype	c diff strain	c diff dose value	c diff dose units	c diff dose vegetative/spores	daily dosage	total dosage	dosage value	dosage units	dosage times per day	dosage duration	intervention	result
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu								negativecontrol	1.0
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									oldcontrol	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									youngcontrol	0.5384615384615384
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/33305657	2020	acute	n/a	c57bl/6	n/a	84		mouse		neomycin+metronidazole+vancomycin+clindamycin+challenge	cumulativemortality	f	p	87	vpi10463	1000		spores	1000	1000	10^3	spores	qd	1	ntcd-035	1.0
https://pubmed.ncbi.nlm.nih.gov/33305657	2020	acute	n/a	c57bl/6	n/a	84		mouse		neomycin+metronidazole+vancomycin+clindamycin+challenge	cumulativemortality	f	p	87	vpi10463	1000		spores							negativecontrol	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	cadazolid	0.4
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10	50	10	mg/kg	qd	5	cadazolid	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	100	500	100	mg/kg	qd	5	cadazolid	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	cadazolid	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	cadazolid	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	cadazolid	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	cadazolid	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	cadazolid	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	cadazolid	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores							control	0.06666666666666667
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	cadazolid	0.2
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10	50	10	mg/kg	qd	5	cadazolid	0.4
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	100	500	100	mg/kg	qd	5	cadazolid	0.8
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	cadazolid	0.4
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	cadazolid	0.6
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	cadazolid	0.2
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	cadazolid	0.5
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	cadazolid	0.6
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	cadazolid	0.4
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores							control	0.06666666666666667
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores							control	0.25
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	200	1400	100	mg/kg	bid	7	mbx-500	0.8888888888888888
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	400	2800	200	mg/kg	bid	7	mbx-500	0.75
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	800	5600	400	mg/kg	bid	7	mbx-500	1.0
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.3
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	1.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	1.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu								vehiclecontrol	0.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	0.3
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	0.9
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu								vehiclecontrol	0.0
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu								untreatedcontrol	0.2
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu								untreatedcontrol	0.2
https://pubmed.ncbi.nlm.nih.gov/26461425	2015	acute	n/a	c57bl/6	f	39		mouse		ampicillin,kanamycin,gentamycin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	p	27	uk6	10000000		spores	2000000	4000000	10^6	vegetativecells	bid	2	clostridiumdifficilecd37	0.8
https://pubmed.ncbi.nlm.nih.gov/26461425	2015	acute	n/a	c57bl/6	f	39		mouse		ampicillin,kanamycin,gentamycin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	p	27	uk6	10000000		spores							control	0.2
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	100	500	50	mg/kg	bid	5	mdx	0.7272727272727273
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	100	500	50	mg/kg	bid	5	ucb	1.0
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	mdx	0.7272727272727273
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	ucb	1.0
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	100	500	50	mg/kg	bid	5	mdx	0.18181818181818182
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	100	500	50	mg/kg	bid	5	ucb	0.7272727272727273
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	mdx	0.09090909090909091
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	ucb	0.0
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores							negativecontrol	0.1
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores							negativecontrol	0.1
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	rep3123	0.75
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	rep3123	0.875
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative							control	0.0
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	rep3123	0.625
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	rep3123	0.75
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative							control	0.0
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	1	6	1	mg/kg	qd	6	metronidazole	0.0
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	metronidazole	0.6
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores							control	0.2
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-fd	0.7
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-g10	0.55
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-g80	0.6
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							negativecontrol	0.2
https://pubmed.ncbi.nlm.nih.gov/23939887/	2013	acute	n/a	goldensyrian	m	49		hamster		clindamycin+challenge	mortality	f	p	27	bi1	100	cfu	spores	1000000		10^6	cfuofspores	qd	1	m3,antcdstrain	1.0
https://pubmed.ncbi.nlm.nih.gov/23939887/	2013	acute	n/a	goldensyrian	m	49		hamster		clindamycin+challenge	mortality	f	p	27	bi1	100	cfu	spores	1000000		10^6	cfuofspores	qd	1	t7,antcdstrain	1.0
https://pubmed.ncbi.nlm.nih.gov/23939887/	2013	acute	n/a	goldensyrian	m	49		hamster		clindamycin+challenge	mortality	f	p	27	bi1	100	cfu	spores							control	0.0
https://pubmed.ncbi.nlm.nih.gov/23939887/	2013	sustained	n/a	goldensyrian	m	49		hamster		clindamycin+challenge	mortality	f	p	27	bi1	100	cfu	spores	1000000	1000000	10^6	cfuofspores	qd	1	m3,antcdstrain	0.9
https://pubmed.ncbi.nlm.nih.gov/23939887/	2013	sustained	n/a	goldensyrian	m	49		hamster		clindamycin+challenge	mortality	f	p	27	bi1	100	cfu	spores	1000000	1000000	10^6	cfuofspores	qd	1	t7,antcdstrain	0.8
https://pubmed.ncbi.nlm.nih.gov/23939887/	2013	sustained	n/a	goldensyrian	m	49		hamster		clindamycin+challenge	mortality	f	p	27	bi1	100	cfu	spores							control	0.0
https://pubmed.ncbi.nlm.nih.gov/25486992	2015	acute	n/a	c57bl/6	n/a	49		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge+20dayrecovery+challenge	survival	f	p	27	uk1	100000		spores	10	50	10	mg/kg	qd	5	actoxumab-bezlotoxumab	1.0
https://pubmed.ncbi.nlm.nih.gov/25486992	2015	acute	n/a	c57bl/6	n/a	49		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge+20dayrecovery+challenge	survival	f	p	27	uk1	100000		spores	2	10	2	mg/kg	qd	5	actoxumab-bezlotoxumab	1.0
https://pubmed.ncbi.nlm.nih.gov/25486992	2015	acute	n/a	c57bl/6	n/a	49		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	survival	f	t	27	uk1	100000		spores	5	25	5	mg/kg	qd	5	actoxumab-bezlotoxumab	0.8
https://pubmed.ncbi.nlm.nih.gov/25486992	2015	acute	n/a	c57bl/6	n/a	49		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge+20dayrecovery+challenge	survival	f	p	27	uk1	100000		spores	50	250	50	mg/kg	qd	5	actoxumab-bezlotoxumab	1.0
https://pubmed.ncbi.nlm.nih.gov/25486992	2015	acute	n/a	c57bl/6	n/a	49		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	survival	f	p	27	uk1	100000		spores	50	50	50	mg/kg	qd	1	actoxumab-bezlotoxumab	1.0
https://pubmed.ncbi.nlm.nih.gov/25486992	2015	acute	n/a	c57bl/6	n/a	49		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	survival	f	t	27	uk1	100000		spores	50	50	50	mg/kg	qd	1	actoxumab-bezlotoxumab	1.0
https://pubmed.ncbi.nlm.nih.gov/25486992	2015	acute	n/a	c57bl/6	n/a	49		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	survival	f	p	27	uk1	100000		spores	50	50	50	mg/kg	qd	1	n297qmutantactoxumab-bezlotoxumab	1.0
https://pubmed.ncbi.nlm.nih.gov/25486992	2015	acute	n/a	c57bl/6	n/a	49		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge+20dayrecovery+challenge	survival	f	p	27	uk1	100000		spores							control	0.2
https://pubmed.ncbi.nlm.nih.gov/25486992	2015	acute	n/a	c57bl/6	n/a	49		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	survival	f	p	27	uk1	100000		spores							control	0.5333333333333333
https://pubmed.ncbi.nlm.nih.gov/25486992	2015	acute	n/a	c57bl/6	n/a	49		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	survival	f	t	27	uk1	100000		spores							control	0.1
https://pubmed.ncbi.nlm.nih.gov/25486992	2015	sustained	n/a	c57bl/6	n/a	49		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge+20dayrecovery+challenge	survival	f	p	27	uk1	100000		spores	10	50	10	mg/kg	qd	5	actoxumab-bezlotoxumab	1.0
https://pubmed.ncbi.nlm.nih.gov/25486992	2015	sustained	n/a	c57bl/6	n/a	49		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge+20dayrecovery+challenge	survival	f	p	27	uk1	100000		spores	2	10	2	mg/kg	qd	5	actoxumab-bezlotoxumab	1.0
https://pubmed.ncbi.nlm.nih.gov/25486992	2015	sustained	n/a	c57bl/6	n/a	49		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	survival	f	t	27	uk1	100000		spores	5	25	5	mg/kg	qd	5	actoxumab-bezlotoxumab	0.8
https://pubmed.ncbi.nlm.nih.gov/25486992	2015	sustained	n/a	c57bl/6	n/a	49		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	survival	f	p	27	uk1	100000		spores	50	50	50	mg/kg	qd	1	actoxumab-bezlotoxumab	1.0
https://pubmed.ncbi.nlm.nih.gov/25486992	2015	sustained	n/a	c57bl/6	n/a	49		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	survival	f	t	27	uk1	100000		spores	50	50	50	mg/kg	qd	1	actoxumab-bezlotoxumab	1.0
https://pubmed.ncbi.nlm.nih.gov/25486992	2015	sustained	n/a	c57bl/6	n/a	49		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	survival	f	p	27	uk1	100000		spores	50	50	50	mg/kg	qd	1	n297qmutantactoxumab-bezlotoxumab	1.0
https://pubmed.ncbi.nlm.nih.gov/25486992	2015	sustained	n/a	c57bl/6	n/a	49		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge+20dayrecovery+challenge	survival	f	p	27	uk1	100000		spores	50	250	50	mg/kg	qd	5	actoxumab-bezlotoxumab	1.0
https://pubmed.ncbi.nlm.nih.gov/25486992	2015	sustained	n/a	c57bl/6	n/a	49		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge+20dayrecovery+challenge	survival	f	p	27	uk1	100000		spores							control	0.2
https://pubmed.ncbi.nlm.nih.gov/25486992	2015	sustained	n/a	c57bl/6	n/a	49		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	survival	f	p	27	uk1	100000		spores							control	0.5333333333333333
https://pubmed.ncbi.nlm.nih.gov/25486992	2015	sustained	n/a	c57bl/6	n/a	49		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	survival	f	t	27	uk1	100000		spores							control	0.1
https://pubmed.ncbi.nlm.nih.gov/25486992	2015	acute	n/a	cd1	n/a	49		mouse		25ngeachtcdaandtcdb+ip	survival	f	p	87	vpi10463	5	ug		0.1	0.1	0.1	mg/kg	qd	1	actoxumab-bezlotoxumab	0.0
https://pubmed.ncbi.nlm.nih.gov/25486992	2015	acute	n/a	cd1	n/a	49		mouse		25ngeachtcdaandtcdb+ip	survival	f	p	87	vpi10463	5	ug		1	1	1	mg/kg	qd	1	actoxumab-bezlotoxumab	0.0
https://pubmed.ncbi.nlm.nih.gov/25486992	2015	acute	n/a	cd1	n/a	49		mouse		25ngeachtcdaandtcdb+ip	survival	f	p	87	vpi10463	5	ug		10	10	10	mg/kg	qd	1	actoxumab-bezlotoxumab	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/25486992	2015	acute	n/a	cd1	n/a	49		mouse		25ngeachtcdaandtcdb+ip	survival	f	p	87	vpi10463	5	ug								control	0.0
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		100	1000	50 vancomycin + 50 metronidazole	mg/kg	qd	10	vancomycin+metronidazole	0.8333333333333334
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	metronidazole	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu								infectedcontrol	0.4444444444444444
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		100	1000	50 vancomycin + 50 metronidazole	mg/kg	qd	10	vancomycin+metronidazole	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	metronidazole	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu								infectedcontrol	0.4444444444444444
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	metronidazole	0.5
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu								vehiclecontrol	0.3
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	metronidazole	0.5
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu								vehiclecontrol	0.3
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	p	87	vpi10463	1000000	cfu	vegetative	50	100	50	mg/kg	qd	2	actoxumab-bezlotoxumab	1.0
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative							vehiclecontrol	0.3
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	p	87	vpi10463	1000000	cfu	vegetative	50	100	50	mg/kg	qd	2	actoxumab-bezlotoxumab	0.9
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative							vehiclecontrol	0.3
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse	aninhibitorofpyruvate:ferredoxinoxidoreductase(pfor)	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	amixicile	0.5
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	nitazoxanide	0.25
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vpc161183	0.25
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu								control	0.25
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse	aninhibitorofpyruvate:ferredoxinoxidoreductase(pfor)	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	amixicile	0.5
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	nitazoxanide	0.25
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vpc161183	0.25
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu								control	0.25
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	nitazoxanide	0.625
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	nitazoxanide	0.625
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse	aninhibitorofpyruvate:ferredoxinoxidoreductase(pfor)	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	amixicile	0.7
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	amixicile+vancomycin	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.8
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu								control	0.0
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse	aninhibitorofpyruvate:ferredoxinoxidoreductase(pfor)	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	amixicile	0.7
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	amixicile+vancomycin	0.16666666666666666
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.2
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu								control	0.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									control	0.25
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									control	0.25
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	metronidazole	0.8333333333333334
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	metronidazole	0.8333333333333334
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	0.16666666666666666
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	atl370	0.16666666666666666
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin+atl370	1.0
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	atl370	0.16666666666666666
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin+atl370	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative							vehiclecontrol	0.13636363636363635
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative							vehiclecontrol	0.13636363636363635
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative							pbscontrol	0.0
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	1.8	7.2	0.6	mg/kg	tid	4	it2s4	0.9285714285714286
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	36	144	12	mg/kg	tid	4	it2s4	1.0
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	900	3600	300	mg/kg	tid	4	it2s4	1.0
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	18	72	6	mg/kg	tid	4	it2s4	1.0
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	180	720	60	mg/kg	tid	4	it2s4	1.0
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	1.8	7.2	0.6	mg/kg	tid	4	it2s4	0.42857142857142855
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	36	144	12	mg/kg	tid	4	it2s4	0.4117647058823529
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	900	3600	300	mg/kg	tid	4	it2s4	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	18	72	6	mg/kg	tid	4	it2s4	0.7857142857142857
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	180	720	60	mg/kg	tid	4	it2s4	0.36
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	cadazolid	0.4672897196261682
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	cadazolid	0.9649122807017544
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	cadazolid	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores							cadazolidcontrol	0.17518248175182483
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores							vancomycincontrol	0.125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	cadazolid	0.40186915887850466
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	cadazolid	0.9210526315789473
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	cadazolid	0.8785046728971962
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores							cadazolidcontrol	0.12408759124087591
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores							vancomycincontrol	0.125
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu								control	0.5
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu								control	0.5
https://pubmed.ncbi.nlm.nih.gov/33202811	2020	acute	n/a	goldensyrian	f		95	hamster		clindamycin+challenge	cumulativemortality	f	p	27	cd13-12	5000	cfu	spores	1000000	1000000	10^6	spores	qd	1	pcd130+027	0.8888888888888888
https://pubmed.ncbi.nlm.nih.gov/33202811	2020	acute	n/a	goldensyrian	f		95	hamster		clindamycin+challenge	cumulativemortality	f	p	27	cd13-12	5000	cfu	spores	1000000	1000000	10^6	spores	qd	1	pcd182+027	0.8888888888888888
https://pubmed.ncbi.nlm.nih.gov/33202811	2020	acute	n/a	goldensyrian	f		95	hamster		clindamycin+challenge	cumulativemortality	f	p	27	cd13-12	5000	cfu	spores							negativecontrol	0.0
https://pubmed.ncbi.nlm.nih.gov/33202811	2020	sustained	n/a	goldensyrian	f		95	hamster		clindamycin+challenge	cumulativemortality	f	p	27	cd13-12	5000	cfu	spores	1000000	1000000	10^6	spores	qd	1	pcd130+027	0.5555555555555556
https://pubmed.ncbi.nlm.nih.gov/33202811	2020	sustained	n/a	goldensyrian	f		95	hamster		clindamycin+challenge	cumulativemortality	f	p	27	cd13-12	5000	cfu	spores	1000000	1000000	10^6	spores	qd	1	pcd182+027	0.8888888888888888
https://pubmed.ncbi.nlm.nih.gov/33202811	2020	sustained	n/a	goldensyrian	f		95	hamster		clindamycin+challenge	cumulativemortality	f	p	27	cd13-12	5000	cfu	spores							negativecontrol	0.0
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	cb-183,315	0.9696969696969697
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	cb-183,315	1.0
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	cb-183,315	1.0
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores							control	0.0
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	cb-183,315	0.7575757575757576
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	cb-183,315	0.5
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	cb-183,315	0.8125
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores							control	0.0
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	surotomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores							vehiclecontrol	0.0
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	surotomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores							vehiclecontrol	0.0
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	3.12	12.48	1.56	mg/kg	bid	4	kibdelomycin	0.8
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	25	100	12.5	mg/kg	bid	4	kibdelomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	kibdelomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	3.12	12.48	1.56	mg/kg	bid	4	kibdelomycin	0.8
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	25	100	12.5	mg/kg	bid	4	kibdelomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	kibdelomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/16966409	2006	acute	n/a	swisswebster	n/a			mouse	antibody	toxinaintraperitoneally	survival	f	p	87	vpi10463	100	ngtoxina				100 to 250	ug			1b11	0.24
https://pubmed.ncbi.nlm.nih.gov/16966409	2006	acute	n/a	swisswebster	n/a			mouse	antibody	toxinaintraperitoneally	survival	f	p	87	vpi10463	100	ngtoxina				100 to 250	ug			3h2	0.7428571428571429
https://pubmed.ncbi.nlm.nih.gov/16966409	2006	acute	n/a	swisswebster	n/a			mouse	antibody	toxinaintraperitoneally	survival	f	p	87	vpi10463	100	ngtoxina				100 to 250	ug			cda1	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/16966409	2006	acute	n/a	swisswebster	n/a			mouse	antibody	toxinaintraperitoneally	survival	f	p	87	vpi10463	100	ngtoxina								control-irrelevanthumab	0.22857142857142856
https://pubmed.ncbi.nlm.nih.gov/16966409	2006	acute	n/a	goldensyrian	n/a		75	hamster		clindamycin+challenge	cumulativemortality	f	p	87	vpi10463	140	cfu	spores			10 to 50	mg/kg	qd	4	mdx1388	0.17647058823529413
https://pubmed.ncbi.nlm.nih.gov/16966409	2006	acute	n/a	goldensyrian	n/a		75	hamster		clindamycin+challenge	cumulativemortality	f	p	87	vpi10463	140	cfu	spores	50	200	50	mg/kg	qd	4	cda1	0.5476190476190477
https://pubmed.ncbi.nlm.nih.gov/16966409	2006	acute	n/a	goldensyrian	n/a		75	hamster		clindamycin+challenge	cumulativemortality	f	p	87	vpi10463	140	cfu	spores			50 CDA1 + 10 to 50 MDX1388	mg/kg	qd	4	cda1+mdx1388	0.9384615384615385
https://pubmed.ncbi.nlm.nih.gov/16966409	2006	acute	n/a	goldensyrian	n/a		75	hamster		clindamycin+challenge	cumulativemortality	f	p	87	vpi10463	140	cfu	spores							control	0.05454545454545454
https://pubmed.ncbi.nlm.nih.gov/16966409	2006	sustained	n/a	goldensyrian	n/a		75	hamster		clindamycin+challenge	cumulativemortality	f	p	87	vpi10463	140	cfu	spores			10 to 50	mg/kg	qd	4	mdx1388	0.0
https://pubmed.ncbi.nlm.nih.gov/16966409	2006	sustained	n/a	goldensyrian	n/a		75	hamster		clindamycin+challenge	cumulativemortality	f	p	87	vpi10463	140	cfu	spores	50	200	50	mg/kg	qd	4	cda1	0.047619047619047616
https://pubmed.ncbi.nlm.nih.gov/16966409	2006	sustained	n/a	goldensyrian	n/a		75	hamster		clindamycin+challenge	cumulativemortality	f	p	87	vpi10463	140	cfu	spores			50 CDA1 + 10 to 50 MDX1388	mg/kg	qd	4	cda1+mdx1388	0.5538461538461539
https://pubmed.ncbi.nlm.nih.gov/16966409	2006	sustained	n/a	goldensyrian	n/a		75	hamster		clindamycin+challenge	cumulativemortality	f	p	87	vpi10463	140	cfu	spores							control	0.0
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	p	12	630	680	cfu	spores	50	200	50	mg/kg	qd	4	actoxumab-bezlotoxumab	0.5
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores							vehiclecontrol	0.0
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	p	12	630	680	cfu	spores	50	200	50	mg/kg	qd	4	actoxumab-bezlotoxumab	0.4
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores							vehiclecontrol	0.0
https://pubmed.ncbi.nlm.nih.gov/16966409	2006	acute	n/a	goldensyrian	n/a		75	hamster		clindamycin+challenge+vancomycin	cumulativemortality	f	t	87	vpi10463	140000	cfu	spores	20	80	20	mg/kg	qd	4	mdx1388	0.26666666666666666
https://pubmed.ncbi.nlm.nih.gov/16966409	2006	acute	n/a	goldensyrian	n/a		75	hamster		clindamycin+challenge+vancomycin	cumulativemortality	f	t	87	vpi10463	140000	cfu	spores	80	320	60 CDA1 + 20 MDX1388	mg/kg	qd	4	cda1+mdx1388	0.6818181818181818
https://pubmed.ncbi.nlm.nih.gov/16966409	2006	acute	n/a	goldensyrian	n/a		75	hamster		clindamycin+challenge+vancomycin	cumulativemortality	f	t	87	vpi10463	140000	cfu	spores	60	240	60	mg/kg	qd	4	cda1	0.5581395348837209
https://pubmed.ncbi.nlm.nih.gov/16966409	2006	acute	n/a	goldensyrian	n/a		75	hamster		clindamycin+challenge+vancomycin	cumulativemortality	f	t	87	vpi10463	140000	cfu	spores							control	0.3780487804878049
https://pubmed.ncbi.nlm.nih.gov/16966409	2006	sustained	n/a	goldensyrian	n/a		75	hamster		clindamycin+challenge+vancomycin	cumulativemortality	f	t	87	vpi10463	140000	cfu	spores	20	80	20	mg/kg	qd	4	mdx1388	0.26666666666666666
https://pubmed.ncbi.nlm.nih.gov/16966409	2006	sustained	n/a	goldensyrian	n/a		75	hamster		clindamycin+challenge+vancomycin	cumulativemortality	f	t	87	vpi10463	140000	cfu	spores	80	320	60 CDA1 + 20 MDX1388	mg/kg	qd	4	cda1+mdx1388	0.6818181818181818
https://pubmed.ncbi.nlm.nih.gov/16966409	2006	sustained	n/a	goldensyrian	n/a		75	hamster		clindamycin+challenge+vancomycin	cumulativemortality	f	t	87	vpi10463	140000	cfu	spores	60	240	60	mg/kg	qd	4	cda1	0.32558139534883723
https://pubmed.ncbi.nlm.nih.gov/16966409	2006	sustained	n/a	goldensyrian	n/a		75	hamster		clindamycin+challenge+vancomycin	cumulativemortality	f	t	87	vpi10463	140000	cfu	spores							control	0.21951219512195122
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.3
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	0.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	25	125	12.5	mg/kg	bid	5	smt19969	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	25	125	12.5	mg/kg	bid	5	smt19969	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.4
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	0.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	smt19969	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	smt19969	0.8
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores							vehiclecontrol	0.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores							vehiclecontrol	0.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.9
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	25	125	12.5	mg/kg	bid	5	smt19969	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	25	125	12.5	mg/kg	bid	5	smt19969	0.9
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.9
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	50	250	25	mg/kg	bid	5	smt19969	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	50	250	25	mg/kg	bid	5	smt19969	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores							vehiclecontrol	0.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores							vehiclecontrol	0.0
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores							control	0.09090909090909091
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores							control	0.0
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	more-dcbg(362e)	1.0
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	more-dcbg(362e)	0.16666666666666666
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	700	50	mg/kg	bid	7	more-dcbg(362e)	0.6
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	700	50	mg/kg	bid	7	more-dcbg(362e)	1.0
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	1400	50	mg/kg	bid	14	more-dcbg(362e)	1.0
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	1400	50	mg/kg	bid	14	more-dcbg(362e)	1.0
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	30	93.75	10	ml/kg	tid	3.125	anti-cd-wpiinducesatcdaneutralizationcapacityof100	1.0
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	30	93.75	10	ml/kg	tid	3.125	anti-cd-wpiinducesatcdaneutralizationcapacityof1000	1.0
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	30	93.75	10	ml/kg	tid	3.125	anti-cd-wpiinducesatcdaneutralizationcapacityof10000	1.0
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	30	93.75	10	ml/kg	tid	3.125	anti-cd-wpiinducesatcdaneutralizationcapacityof100	0.8
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	30	93.75	10	ml/kg	tid	3.125	anti-cd-wpiinducesatcdaneutralizationcapacityof1000	0.5
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	30	93.75	10	ml/kg	tid	3.125	anti-cd-wpiinducesatcdaneutralizationcapacityof10000	1.0
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1
https://pubmed.ncbi.nlm.nih.gov/7309245	1981	acute	n/a	goldensyrian	m		85	hamster		vancomyin+challenge	survivors	f	p		49a	100000	cfu								cecalhomogenates	0.8
https://pubmed.ncbi.nlm.nih.gov/7309245	1981	acute	n/a	goldensyrian	m		85	hamster		vancomyin+challenge	survivors	f	p		49a	100000	cfu								negativecontrol	0.05
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			150	900	150	mg/kg	qd	6	metronidazole	1.0
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			150	900	150	mg/kg	qd	6	nitazoxanide	1.0
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			30	180	30	mg/kg	qd	6	nitazoxanide	0.5
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			75	450	75	mg/kg	qd	6	nitazoxanide	1.0
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000									salinecontrol	0.0
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			150	900	150	mg/kg	qd	6	metronidazole	0.0
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			150	900	150	mg/kg	qd	6	nitazoxanide	0.0
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			30	180	30	mg/kg	qd	6	nitazoxanide	0.0
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			75	450	75	mg/kg	qd	6	nitazoxanide	0.0
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000									salinecontrol	0.0
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	rifalazil	1.0
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu								vehiclecontrol	0.0
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	rifalazil	1.0
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu								vehiclecontrol	0.0
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		100	500	100	mg/kg	qd	5	rifaximin	0.8
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		100	500	100	mg/kg	qd	5	rifaximin	0.9
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		25	125	25	mg/kg	qd	5	rifaximin	0.6
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		25	125	25	mg/kg	qd	5	rifaximin	0.45
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	rifaximin	0.7
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	rifaximin	0.65
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu								vehiclecontrol	0.0
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu								vehiclecontrol	0.0
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		100	500	100	mg/kg	qd	5	rifaximin	1.0
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		25	125	25	mg/kg	qd	5	rifaximin	1.0
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	rifaximin	1.0
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu								vehiclecontrol	0.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsc	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsc	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsc	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000									control	0.6
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000									control	0.75
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsc	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsc	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsc	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000									control	0.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000									control	0.25
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	p		huc2-4	1000000	cfu		1000	7000	1000	mg/kg	qd	7	gt160-246	1.0
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		1000	7000	1000	mg/kg	qd	7	gt160-246	0.7
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		1500	10500	1500	mg/kg	qd	7	gt160-246	0.7
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		210	1050	210	mg/kg	qd	5	metronidazole	1.0
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	p		huc2-4	1000000	cfu		500	3500	500	mg/kg	qd	7	gt160-246	0.8
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		500	3500	500	mg/kg	qd	7	gt160-246	0.9
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	p		huc2-4	1000000	cfu								salinecontrol	0.0
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	p		huc2-4	1000000	cfu		1000	7000	1000	mg/kg	qd	7	gt160-246	0.9
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		1000	7000	1000	mg/kg	qd	7	gt160-246	0.7
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		1500	10500	1500	mg/kg	qd	7	gt160-246	0.7
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		210	1050	210	mg/kg	qd	5	metronidazole	0.2
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	p		huc2-4	1000000	cfu		500	3500	500	mg/kg	qd	7	gt160-246	0.7
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		500	3500	500	mg/kg	qd	7	gt160-246	0.9
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	p		huc2-4	1000000	cfu								salinecontrol	0.0
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores							control	0.0
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	12.5	37.5	6.25	mg/kg	bid	3	359e	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	25	75	12.5	mg/kg	bid	3	359e	0.8333333333333334
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	50	150	25	mg/kg	bid	3	359e	1.0
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	359e	1.0
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	12.5	37.5	6.25	mg/kg	bid	3	more-dcbg(362e)	1.0
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	25	75	12.5	mg/kg	bid	3	more-dcbg(362e)	1.0
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	50	150	25	mg/kg	bid	3	more-dcbg(362e)	1.0
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	more-dcbg(362e)	1.0
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.5
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	1.0
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores							negativecontrol	0.0
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.0
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.16666666666666666
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores							negativecontrol	0.0
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.2
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores							negativecontrol	0.0
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.4
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.0
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	0.5
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores							negativecontrol	0.0
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		300	1500	150	mg/kg	bid	5	metronidazole	1.0
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	rbx14255	1.0
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		300	1500	150	mg/kg	bid	5	metronidazole	0.0
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	rbx14255	0.5
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu								negativecontrol	0.05
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu								negativecontrol	0.0
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		10	50	10	mg/kg	qd	5	smt19969	1.0
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	smt19969	1.0
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		50	250	50	mg/kg	qd	5	smt19969	1.0
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		10	50	10	mg/kg	qd	5	smt19969	0.0
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	smt19969	0.55
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		50	250	50	mg/kg	qd	5	smt19969	0.7
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		10	50	10	mg/kg	qd	5	smt19969	0.9
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	smt19969	0.95
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		50	250	50	mg/kg	qd	5	smt19969	0.95
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		10	50	10	mg/kg	qd	5	smt19969	0.8
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	smt19969	0.9
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		50	250	50	mg/kg	qd	5	smt19969	0.95
